These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35050467)

  • 1. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
    Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
    Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
    Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
    Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma.
    Chen Y; Wu J; You J; Gao M; Lu S; Sun C; Shu Y; Wang X
    Med Phys; 2024 Sep; 51(9):6513-6524. PubMed ID: 38781536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simplified Version of the IASLC Grading System for Invasive Pulmonary Adenocarcinomas With Improved Prognosis Discrimination.
    Bossé Y; Gagné A; Althakfi WA; Orain M; Couture C; Trahan S; Pagé S; Joubert D; Fiset PO; Desmeules P; Joubert P
    Am J Surg Pathol; 2023 Jun; 47(6):686-693. PubMed ID: 37032554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted lung adenocarcinoma.
    Kubota S; Taki T; Miyoshi T; Tane K; Samejima J; Aokage K; Wakabayashi M; Nomura K; Nagamine M; Kojima M; Sakashita S; Sakamoto N; Tsuboi M; Ishii G
    Eur J Cancer; 2024 Aug; 207():114184. PubMed ID: 38936102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma.
    Tan KS; Reiner A; Emoto K; Eguchi T; Takahashi Y; Aly RG; Rekhtman N; Adusumilli PS; Travis WD
    Mod Pathol; 2024 Jul; 37(7):100520. PubMed ID: 38777035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation Study of the International Association for the Study of Lung Cancer Histologic Grading System of Invasive Lung Adenocarcinoma.
    Rokutan-Kurata M; Yoshizawa A; Ueno K; Nakajima N; Terada K; Hamaji M; Sonobe M; Menju T; Date H; Morita S; Haga H
    J Thorac Oncol; 2021 Oct; 16(10):1753-1758. PubMed ID: 33905897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new IASLC grading system for invasive non-mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    J Surg Oncol; 2023 Jan; 127(1):174-182. PubMed ID: 36098331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
    Nomura K; Aokage K; Kaminuma Y; Nakai T; Wakabayashi M; Ikeno T; Koike Y; Taki T; Miyoshi T; Tane K; Samejima J; Ishii G; Tsuboi M
    Int J Clin Oncol; 2024 Mar; 29(3):248-257. PubMed ID: 38319510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
    Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma.
    Liu C; Wang LC; Chang JF; Lin KH; Yeh YC; Hsu PK; Huang CS; Hsieh CC; Hsu HS
    Eur J Surg Oncol; 2024 Oct; 50(10):108540. PubMed ID: 39178686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of the 2020 International Association for the Study of Lung Cancer histologic grading in surgically resected pathologic stage 1 lung adenocarcinomas: Prognostic value and association with computed tomography characteristics.
    Cho IS; Shim HS; Lee HJ; Suh YJ
    Lung Cancer; 2023 Oct; 184():107345. PubMed ID: 37611496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
    Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
    Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
    Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
    Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of mitosis and necrosis in non-mucinous lung adenocarcinomas and correlation with IASLC grading system.
    Serın G; Savaş P; İşgör İŞ; Özdıl A; Mizrak A; Veral A; Nart D
    Histol Histopathol; 2024 Jun; 39(6):703-714. PubMed ID: 37724635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
    Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
    Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
    Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
    World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management.
    Mikubo M; Tamagawa S; Kondo Y; Hayashi S; Sonoda D; Naito M; Shiomi K; Ichinoe M; Satoh Y
    Lung Cancer; 2024 Jan; 187():107445. PubMed ID: 38157805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.